BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 17, 2019
View Archived Issues
Anticoagulants prevent AD symptoms
Read More
P63 is behind thalidomide birth defects
Read More
Milasen, individualized gene therapy for rare genetic disease
Read More
Enterprise Therapeutics receives funding for development of novel CF therapy
Read More
Hepagene begins phase I trial of FXR agonist HPG-1860 for NASH
Read More
First patient enrolled in phase II study of novel cystic fibrosis treatment, BI-1265162
Read More
Further clinical data presented from phase I/II bladder cancer study of Alpha1H
Read More
Positive biomarker results presented from phase I study of XCUR-17
Read More
Preclinical evaluation of novel nonimmunogenic utrophin gene therapy for DMD
Read More
Bi-allelic loss of human APC2 is associated with recessive form of lissencephaly
Read More
New thioredoxin reductase 1 inhibitors identified at the University of Sharjah
Read More
Plexxikon discovers IDO-1 and TDO inhibitors
Read More
In vitro and in vivo characterization of [177Lu]DOTA-G-02113 and [68Ga]DOTA-G-02113 presented
Read More
Newly discovered protein modulates GABA, benzodiazepines
Read More
Relay Therapeutics and DE Shaw Research patent PTPN11 inhibitors
Read More
GC Pharma, Vaxess announce collaboration to develop release patch influenza vaccine
Read More
Shenzhen Targetrx Biotechnology discloses AXL/FLT3 inhibitors
Read More
New adamantane-containing compounds discovered at Hinova Pharmaceuticals
Read More
[68Ga]Ga-DO3A-S01-GCG: a first-in-class GCGR PET tracer with proof of concept in preclinical phase
Read More
UniQure enrolling patients with early manifest Huntington's disease for phase I/II study of AMT-130
Read More
New phase I study explores trivalent conjugate vaccine against invasive Salmonella disease
Read More
Nektar initiates first-in-human study of NKTR-255 in NHL and multiple myeloma
Read More